Autoimmune Diseases  >>  Wosulin 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wosulin 30/70 (recombinant human insulin biosimilar 30% + isophane insulin biosimilar 70%) / Wockhardt
NCT01308437: Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Terminated
3
134
US, RoW
Wosulin (N or 70/30 with R), Wosulin R,, Wosulin N,, Wosulin 70/30, Novolin® (N or 70/30 with R), Novolin® R,, Novolin® N,, Novolin® 70/30
Wockhardt
Type I Diabetes
04/13
04/13

Download Options